OSE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 3.058 EUR 2.41%

Market Cap: €72m

	OSE Immunotherapeutics SA PAR:OSE	FR
	Cambridge Cognition Holdings PLC F:1M7	UK
	Vaudoise Assurances Holding SA SIX:VAHN	CH
T	Trans-China Automotive Holdings Ltd SGX:VI2	HK
F	Fintech SA WSE:FTH	PL
	ProPetro Holding Corp F:2PG	US

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1.389%

Negative 3Y Average Operating Margin

-783%

Declining Operating Margin

-811% > -1.389%

Negative Net Margin

-1.396%

Negative 3Y Average Net Margin

-780%

Declining Net Margin

-769% > -1.396%

Negative Free Cash Flow Margin

-1.380%

Negative 3Y Average Free Cash Flow Margin

-766%

Declining Free Cash Flow Margin

-784% > -1.380%

Negative ROE

-66%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

Declining ROIC

-51% > -68%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.